Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Volume: 1
Issue: 1
Role of Trop-2 as an Actionable Biomarker in Solid Tumors
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer
ESMO 2020 Congress: Focus in Genitourinary Cancers
Updates and New Targets in NSCLC: An OncLive® Scientific Interchange and Workshop
2020 EBMT Meeting Reporter
Considerations for the Management of Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers
Year in Review: Updates in DLBCL Treatment
Updates in Relapsed/Refractory Metastatic Renal Cell Carcinoma: An OncLive® Scientific Interchange and Workshop
Current and Emerging Treatments in Follicular Lymphoma
Antibody-Drug Conjugates in HER2+ Breast Cancer
New Developments in the Use of Immunotherapy for the Treatment of Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
2020 World GI: Updates in HER2+ GI Cancers
Exploring Therapeutic Strategies in Myelodysplastic Syndromes
Volume: 2020
Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
OncLive® provides updates on the treatment of patients with diffuse large B-cell lymphoma through a Scientific Exchange Workshop.
ASCO 2020: Update on Genitourinary Cancers
Advanced HER2-Expressing Breast Cancer: An OncLive® Scientific Interchange and Workshop
My Treatment Approach: HER2-Positive Breast Cancer
Year in Review: Evolving Landscape in Multiple Myeloma
Therapeutic Changes in HER2+ Breast Cancer
Emerging Advances in Gastrointestinal Cancers
2020 Genitourinary Cancers Symposium
Therapeutic Updates in Neuroendocrine Tumors
2019 ESMO Immuno-Oncology Congress
BTK Inhibitors in B-Cell Lymphomas
Recent Advances in HER2+ Breast Cancer
Targeted Advances in ALK+ NSCLC
Rapid Reporter®
Pulmonologists in Cancer Care
Milestones in Medicine: History & Evolving Role of Interferon in Myeloproliferative Neoplasms
MammaPrint High 2 Indication Could Be Predictive Biomarker for Immunotherapy in HR+/HER2– Early Breast Cancer
Linvoseltamab Generates Efficacy Similar to That Seen With Teclistamab in R/R Myeloma
Dostarlimab With Carboplatin/Paclitaxel Shows Survival Benefits in dMMR/MSI-H Endometrial Cancer
Pembrolizumab With Platinum-Based Therapy is Safe and Efficacious in PSCC